RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
Open Access
- 13 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9), e24688
- https://doi.org/10.1371/journal.pone.0024688
Abstract
Characteristic hypoglycemia, hypotriglyceridemia, hypocholesterolemia, lower body mass, and fat as well as pronounced insulin-sensitivity of RLIP76−/− mice suggested to us the possibility that elevation of RLIP76 in response to stress could itself elicit metabolic syndrome (MSy). Indeed, if it were required for MSy, drugs used to treat MSy should have no effect on RLIP76−/− mice. Blood glucose (BG) and lipid measurements were performed in RLIP76+/+ and RLIP76−/− mice, using Ascensia Elite Glucometer® for glucose and ID Labs kits for cholesterol and triglycerides assays. The ultimate effectors of gluconeogenesis are the three enzymes: PEPCK, F-1,6-BPase, and G6Pase, and their expression is regulated by PPARγ and AMPK. The activity of these enzymes was tested by protocols standardized by us. Expressions of RLIP76, PPARα, PPARγ, HMGCR, pJNK, pAkt, and AMPK were performed by Western-blot and tissue staining. The concomitant activation of AMPK and PPARγ by inhibiting transport activity of RLIP76, despite inhibited activity of key glucocorticoid-regulated hepatic gluconeogenic enzymes like PEPCK, G6Pase and F-1,6-BP in RLIP76−/− mice, is a salient finding of our studies. The decrease in RLIP76 protein expression by rosiglitazone and metformin is associated with an up-regulation of PPARγ and AMPK. All four drugs, rosiglitazone, metformin, gemfibrozil and atorvastatin failed to affect glucose and lipid metabolism in RLIP76−/− mice. Studies confirmed a model in which RLIP76 plays a central role in the pathogenesis of MSy and RLIP76 loss causes profound and global alterations of MSy signaling functions. RLIP76 is a novel target for single-molecule therapeutics for metabolic syndrome.Keywords
This publication has 53 references indexed in Scilit:
- 2'-Hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinomaCarcinogenesis: Integrative Cancer Research, 2011
- Glutathione-Conjugate Transport by RLIP76 Is Required for Clathrin-Dependent Endocytosis and Chemical CarcinogenesisMolecular Cancer Therapeutics, 2011
- RLIP76: A versatile transporter and an emerging target for cancer therapyBiochemical Pharmacology, 2010
- Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolismProceedings of the National Academy of Sciences of the United States of America, 2010
- Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosisCancer Letters, 2009
- The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes MellitusJournal of the CardioMetabolic Syndrome, 2009
- RLIP76: A novel glutathione-conjugate and multi-drug transporterBiochemical Pharmacology, 2009
- RLIP76 in Defense of Radiation PoisoningInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Hsf-1 and POB1 Induce Drug Sensitivity and Apoptosis by Inhibiting Ralbp1Journal of Biological Chemistry, 2008
- The Molecular Basis for Oxidative Stress-Induced Insulin ResistanceAntioxidants and Redox Signaling, 2005